A large, real-world study shows that intravascular lithotripsy (IVL) is safe and effective in treating patients with acute coronary syndrome (ACS).
Patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation who are smokers at baseline are at greater risk of death, myocardial infarction (MI) and stent thrombosis (ST) compared with non-smokers, but are at lower risk of repeat revascularization, a long-term pooled analysis shows.
A new research letter shows a decrease in the use of embolic protection devices with transcatheter aortic valve replacement (TAVR) post-PROTECTED TAVR trial results.
Discussions with patients about their requested referrals and treatments can be a point of contention, and curiosity-driven exploration of strategies and perceptions is needed to compromise respect for the patient and the clinician’s obligations.
People who use cannabis are at a significantly greater risk for developing cardiovascular diseases, a new retrospective study shows.
The PerQSeal resorbable vascular patch showed low rates of major vascular complications and rapid hemostasis rates when used for the closure of large bore arteriotomies in the US pivotal PATCH trial.
Supra-annular self-expanding valves (SEV) demonstrate significantly lower dysfunction rates than balloon-expandable valves (BEV) in severe aortic stenosis (AS) patients in the SMART trial at 2-years, with similar clinical outcomes between the two groups.
Data from the PEERLESS registry cohort suggests that large-bore mechanical thrombectomy (LBMT) is safe and effective for intermediate-risk pulmonary embolism (PE) patients unable to receive thrombolytics.
The EkoSonic Endovascular System (EKOS) demonstrates a “significant and substantial” improvement in right ventricular (RV) function in massive or submassive pulmonary embolism (PE) patients across 4 years in the retrospective EKOS PE study.
The use of supra-annular valves (SAV) and intra-annular valves (IAV) as a second prosthesis in transcatheter aortic valve replacement (TAVR)-in-TAVR procedures shows comparable procedural success and early outcomes, an analysis of international registry data suggests.
Natalie Morrison, CRTonline.org
Jeanne Burke, CRTonline.org
Bailey G. Salimes, CRTonline.org
Will Chu, CRTonline.org
Michael Mahmoudi, MD - D van Ginkel, et al.; TAVI. NEJM 2025; 392:438-449
Michael Mahmoudi, MD - S Jolly, et al.; NEJM 2025; 392:643-652
Michael Mahmoudi, MD - S Jolly et al.; NEJM 2025; 392:633-642
Michael Mahmoudi, MD - P Generreux, et al.; NEJM 2025; NEJM 2025; 392:217-227
GLOBE NEWSWIRE
Do you believe hospitals are doing enough to protect staff from radiation in the cardiac catheterization lab?
Yes
No
Armando Pérez de Prado, Jeremías Bayón, Ignacio Sánchez Pérez, José Moreu Burgos, Pablo Aguar Carrascosa, Alberto Rodrigues, Luis Fernández González, Elena Sánchez Lacuesta, Eduardo Pinar, Vicente Peral, Fermín Sainz Laso, José Ramón Rumoroso, Alfonso Torres, Manel Sabaté, Bruno García del Blanco and Ramiro Trillo Nouche
Imran Naeem Aziz, Ahmad Jabri, Ying Xu, Seth Bilazarian, Dana Bentley, Amir Kaki, Allison Dupont, William O'Neill, Herbert D. Aronow, Alejandro Lemor, Hady Lichaa, Alexander G. Truesdell and Mir B. Basir
Taha Mansoor, Maninder Randhawa, Mahmoud Ismayl, Austin Brubaker and Santhosh K.G. Koshy
Shayna Chotai, Ahmed Salih, Fiyyaz Ahmed-Jushuf, Michael Foley and Rasha K. Al-Lamee
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details